Physician profile
James Wagner
NPI 1942234851
$4,692.55
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,663 · 2020: $982 · 2021: $968 · 2022: $944 · 2023: $107 · 2024: $28.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,780.49 | 2019-2023 | Venovo |
| Inari Medical, INC. | $838.59 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merit Medical Systems INC | $706.12 | 2022 | |
| Abbott Laboratories | $428.00 | 2019-2021 | |
| Penumbra, INC. | $399.16 | 2019 | |
| Medistim USA, INC. | $238.10 | 2022 | |
| W. L. Gore & Associates, INC. | $130.59 | 2019 | |
| Medtronic, INC. | $55.18 | 2021-2024 | In.Pact Av |
| Medtronic Vascular, INC. | $40.00 | 2019 | |
| Terumo Medical Corporation | $31.81 | 2020 | |
| Mauna Kea Technologies, INC. | $15.03 | 2019 | |
| Lemaitre Vascular, INC. | $14.74 | 2023 | Artegraft Vascular Graft |
| Cardiovascular Systems INC. | $14.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.